The following information is available for this conference.
How is the Global Partnership contributing to international health security as the global environment shifts? With biotechnology capabilities now globally spread, what are the implications for the non-proliferation enterprise? Should it be more concerned with assessing latency and risk than preventing spread, and how can this be made effective? What are the prospects for ‘soft engagement’ making progress? How can different sectors collaborate and ensure their efforts are coordinated? PARTICIPATION IN THIS CONFERENCE IS BY INVITATION ONLY.
Download the conference programme (PDF 37Kb approx) - published 26/01/2010